A device that analyzes blood levels of prostate-specific antigen (PSA) is one of the first doctor’s-office uses of microfluidics–technology that can manipulate fluids on a chip at microscopic scales. When a cartridge bearing a blood sample is inserted into the tabletop device, an accurate reading can be completed in 15 minutes, helping monitor the health of patients with prostate cancer. The procedure used now involves sending a sample to a lab for analysis, which often takes a day or two. The device received European approval in June.
Credit: Christopher Harting
Product: Claros DX 1
Cost: To be announced in late 2010
Availability: Late 2010 in selected European markets
Other products in this section:
Gain the insight you need on emerging technologies at EmTech MIT.Learn more and register
US scientist who edited human embryos with CRISPR responds to critics
Can we safely fix the DNA of human embryos in a lab dish?
Data-mining medieval text reveals medically bioactive ingredients
Medieval apothecaries used recipes with significant antibacterial properties, researchers say.
Million-person genetic study finds gene patterns linked to how long people stay in school
Researchers explore genetic “scores” that may predict educational success.